2 most recent filings and news items mentioning SILO. Updated every 60 seconds.
RegulatoryJun 18, 2026Positive
Silo Pharma announced it regained compliance with Nasdaq's minimum closing bid price requirement as of June 17, 2026, resolving a listing qualification matter. The company continues trading on the Nasdaq Capital Market while advancing its lead PTSD drug candidate SPC-15 toward cl
View filing at SEC.gov →
RestructuringJun 3, 2026Negative
Silo Pharma, Inc. filed a Certificate of Change to reduce authorized common shares from 100 million to 6.67 million through a 15-for-1 reverse stock split, with fractional shares rounded up. The restructuring is a common defensive measure to maintain exchange listing compliance a
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.